Phio Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed lower by more than 100 points on Tuesday. When insiders purchase or sell…
Sypris Solutions And 3 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by around 0.2% on Monday. When insiders purchase or sell shares, it…
Phio Pharmaceuticals Completes Dosing In First Patient Cohort In PH-762 Phase 1b Dose-Escalation Study
-PH-762 is Phio's lead product candidate -Screening on the next cohort is on-goingMARLBOROUGH, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday’s session after the company reported worse-than-expected quarterly financial results.…
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers ImmunityBio (NASDAQ:IBRX) shares moved upwards by 32.0% to $6.52 during Tuesday’s pre-market session. The company’s market cap…
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today’s pre-market trading after the company agreed to be acquired…
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Nuwellis (NASDAQ:NUWE) stock rose 46.8% to $0.48 during Monday’s after-market session. The company’s market cap stands at…
Why Is Penny Stock Phio Pharmaceuticals Trading Higher On Monday?
Phio Pharmaceuticals unveils findings on PH-762, a promising candidate for cancer therapy. Discover its rapid cell uptake and tumor-inhibiting potential.
Phio’s Intratumoral Injection Of PH-762 Significantly Inhibits Tumor Growth In Murine Tumor Models And May Generate Memory-Specific T Cells; Injection In Murine Tumors Shows The Compound Is Well Tolerated
-Injection in murine tumors shows the compound is well tolerated-Studies support ongoing clinical trial of PH-762 as a neoadjuvant therapy for treatment of cSCC, melanoma, or Merkel cell carcinomaMARLBOROUGH, Mass.,
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers SINTX Techs (NASDAQ:SINT) shares moved upwards by 79.8% to $0.42 during Wednesday’s pre-market session. The company’s market…